Latest Breaking News On - Karen hunady - Page 3 : comparemela.com

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomHannah deresiewiczKaren hunadyBrittany leighStern investor relations incSyros pharmaceuticalsLifesci communicationsCorporate communications investor relationsNasdaq listing ruleStock incentiveCorporate communicationsInvestor relationsSci communications

Syros Pharmaceuticals (SYRS) Presents Data from Phase 1/1b Clinical Trial of SY-5609

Syros Pharmaceuticals (SYRS) Presents Data from Phase 1/1b Clinical Trial of SY-5609
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKaren hunadyBrittany leighDavida rothHannah deresiewiczAmerican society for clinical oncologyExchange commissionCorporate communications investor relationsSyros pharmaceuticalsStern investor relations incLifesci communicationsWall streetClinical oncologyAnnual meetingChief medical officerDemonstrate encouraging clinical activity

Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals First Quarter 2023 Financial Results Conference Call. [Operator Instructions].

United statesNancy simonianJason butlerJason haasKaren hunadyConley cheeDavid rothPiper sandlerEric olsonChristian stevensMark breidenbachTed tenthoffPhil nadeauCorporate communications at syrosHealth photoSyros pharmaceuticals inc

Syros to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 2, 2023

Syros to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 2, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomKaren hunadyHannah deresiewiczBrittany leighStern investor relations incLifesci communicationsSyros pharmaceuticalsCorporate communications investor relationsWall streetCorporate communicationsInvestor relationsSci communications

Syros Pharmaceuticals (SYRS) Granted FDA Fast Track Designation for Tamibarotene

Syros Pharmaceuticals (SYRS) Granted FDA Fast Track Designation for Tamibarotene
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavida rothKaren hunadyHannah deresiewiczBrittany leighStern investor relations incSyros pharmaceuticalsDrug administrationCorporate communications investor relationsExchange commissionSyros pharmaceuticals incLifesci communicationsUnited states foodFast track designationFast trackChief medical officer